Michael Brady
FounderHelping BioPharma teams evaluate therapeutic opportunities. Passionate about building AI-native software. Boston native.
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Maven Bio is a live intelligence platform for biopharma teams. It continuously monitors clinical, regulatory, company, and deal developments, identifies what matters to each team's priorities, and delivers signals and updates to keep key documents current. Its monitoring agent can apply edits automatically, with sources attached and the option to roll back changes.
Maven runs thousands of monitors across company and individual product websites, trade press, health technology assessment bodies, and patient advocacy groups worldwide. Teams use that intelligence to maintain competitive views, asset screens, and recurring briefs, in Maven or through connected AI assistants and custom workflows.
Previously RightPage
Helping BioPharma teams evaluate therapeutic opportunities. Passionate about building AI-native software. Boston native.
Proactive Biopharma intelligence. Passionate about helping teams in life sciences navigate complexity with the right information at the right time.
Founded 2023 · Source
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.